Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1984 1
1991 1
1993 1
1997 1
2000 1
2002 1
2003 1
2004 1
2005 1
2006 3
2007 1
2008 2
2011 2
2012 1
2013 7
2014 6
2015 2
2016 2
2017 7
2018 2
2019 3
2020 5
2021 5
2022 5
2023 9
2024 5
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.
Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH. Dubois B, et al. Lancet Neurol. 2021 Jun;20(6):484-496. doi: 10.1016/S1474-4422(21)00066-1. Epub 2021 Apr 29. Lancet Neurol. 2021. PMID: 33933186 Free PMC article. Review.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
In vivo single-cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection.
Dumigan A, Cappa O, Morris B, Sá Pessoa J, Calderon-Gonzalez R, Mills G, Lancaster R, Simpson D, Kissenpfennig A, Bengoechea JA. Dumigan A, et al. EMBO Mol Med. 2022 Dec 7;14(12):e16888. doi: 10.15252/emmm.202216888. Epub 2022 Nov 7. EMBO Mol Med. 2022. PMID: 36337046 Free PMC article.
Glycolysis characterises M(Kp) metabolism, and inhibition of glycolysis results in clearance of intracellular Klebsiella. Capsule polysaccharide governs M(Kp). Klebsiella also skews human macrophage polarisation towards M(Kp) in a type I IFN-IL10-STAT6-depend …
Glycolysis characterises M(Kp) metabolism, and inhibition of glycolysis results in clearance of intracellular Klebsiella. Capsule pol …
Sharing brain imaging data in the Open Science era: how and why?
Giehl K, Mutsaerts HJ, Aarts K, Barkhof F, Caspers S, Chetelat G, Colin ME, Düzel E, Frisoni GB, Ikram MA, Jovicich J, Morbelli S, Oertel W, Paret C, Perani D, Ritter P, Segura B, Wisse LEM, De Witte E, Cappa SF, van Eimeren T. Giehl K, et al. Lancet Digit Health. 2024 Jul;6(7):e526-e535. doi: 10.1016/S2589-7500(24)00069-4. Lancet Digit Health. 2024. PMID: 38906618 Free article. Review.
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
Morabito A, Gebbia V, Di Maio M, Cinieri S, Viganò MG, Bianco R, Barbera S, Cavanna L, De Marinis F, Montesarchio V, Costanzo R, Sandomenico C, Montanino A, Mancuso G, Russo P, Nacci A, Giordano P, Daniele G, Piccirillo MC, Rocco G, Gridelli C, Gallo C, Perrone F. Morabito A, et al. Lung Cancer. 2013 Jul;81(1):77-83. doi: 10.1016/j.lungcan.2013.04.008. Epub 2013 May 1. Lung Cancer. 2013. PMID: 23643177 Clinical Trial.
No prospective randomized trial has tested the addition of cisplatin to single-agent chemotherapy in patients with advanced NSCLC and PS2. CAPPA-2 was a multicenter, randomized phase 3 study for first-line treatment of PS2 patients with advanced NSCLC. ...Patients in stand …
No prospective randomized trial has tested the addition of cisplatin to single-agent chemotherapy in patients with advanced NSCLC and PS2. …
Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control.
Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS. Fridman M, et al. Neuropsychiatr Dis Treat. 2017 Feb 13;13:443-455. doi: 10.2147/NDT.S121639. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 28243096 Free PMC article.
The caregiver perspective on pediatric attention-deficit/hyperactivity disorder (ADHD) study (CAPPA) was a web-based, cross-sectional survey of caregivers of children and adolescents (6-17 years of age) with ADHD and was conducted in 10 European countries. CAPPA inc …
The caregiver perspective on pediatric attention-deficit/hyperactivity disorder (ADHD) study (CAPPA) was a web-based, cross-sectional …
Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities.
Frisoni GB, Ribaldi F, Allali G, Bieth T, Brioschi Guevara A, Cappa S, Cipolotti L, Frederiksen KS, Georges J, Jessen F, Koch G, Masters H, Mendes AJ, Frölich L, Garibotto V, Grau-Rivera O, Pozzi FE, Religa D, Rostamzadeh A, Shallcross L, Shenkin SD, van der Flier WM, Vernooij MW, Visser LNC, Cummings JL, Scheltens P, Dubois B, Moro E, Bassetti CLA, Kivipelto M. Frisoni GB, et al. J Prev Alzheimers Dis. 2025 May;12(5):100098. doi: 10.1016/j.tjpad.2025.100098. Epub 2025 Mar 17. J Prev Alzheimers Dis. 2025. PMID: 40102145 Free PMC article. Review.
The science of micronutrients in clinical practice - Report on the ESPEN symposium.
Berger MM, Amrein K, Barazzoni R, Bindels L, Bretón I, Calder PC, Cappa S, Cuerda C, D'Amelio P, de Man A, Delzenne NM, Forbes A, Genton L, Gombart AF, Joly F, Laviano A, Matthys C, Phyo PP, Ravasco P, Serlie MJ, Shenkin A, Stoffel NU, Talwar D, van Zanten ARH. Berger MM, et al. Clin Nutr. 2024 Jan;43(1):268-283. doi: 10.1016/j.clnu.2023.12.006. Epub 2023 Dec 9. Clin Nutr. 2024. PMID: 38104489 Free article.
Structure-based design of potent and selective inhibitors of the HECT ligase NEDD4.
Maspero E, Cappa A, Weber J, Trifirò P, Amici R, Bruno A, Fagà G, Cecatiello V, Fattori R, Leuzzi B, Taibi V, Meroni G, Pasi M, Romussi A, Sartori L, Villa M, Vultaggio S, Cirò M, Soffientini P, Lombardo L, Dahe S, Bachi A, Varasi M, Rossi M, Pasqualato S, Mercurio C, Polo S. Maspero E, et al. Commun Chem. 2025 May 28;8(1):164. doi: 10.1038/s42004-025-01557-4. Commun Chem. 2025. PMID: 40437006 Free PMC article.
Among these, compound 32 emerged as a potent lead (IC(50) = 0.12 M) with favorable pharmacokinetic properties, including oral bioavailability, paving the way for future in vivo efficacy studies....
Among these, compound 32 emerged as a potent lead (IC(50) = 0.12 M) with favorable pharmacokinetic properties, including oral bioavai …
78 results